University Hospital, Basel, Switzerland clinical trial pipeline

5 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 2 with minor changes only.

1. Notable

   EryAdo · Daily Erythritol Versus Sucrose Intake Over 5 Weeks on…EryAdo · Daily Erythritol Versus Sucrose Intake Over 5 Weeks on Glucose Tolerance in Adolescents

   Primary endpoint(s) modified

   Also in this update: Primary and study completion pushed from Jul 2026 to Nov 2026; Interventions modified

   University Hospital, Basel, Switzerland·Not applicable· NCT04966299· Registry history of NCT04966299 on ClinicalTrials.gov (opens the registry)

   Sep 30, 2026

2. Notable

   BASEL-PMI · Incidence and Outcome of Perioperative Myocardial…BASEL-PMI · Incidence and Outcome of Perioperative Myocardial Injury After Non-cardiac Surgery

   Enrollment reopened

   University Hospital, Basel, Switzerland·Not specified· NCT02573532· Registry history of NCT02573532 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

3. Notable

   MEOS · Acute Effects of Intravenous 5-MeO-DMT in Healthy…MEOS · Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants

   Primary and study completion moved earlier from Mar 1, 2028 to Mar 1, 2027

   University Hospital, Basel, Switzerland·Phase 1· NCT07444788· Registry history of NCT07444788 on ClinicalTrials.gov (opens the registry)

   Oct 9, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.